What is Lara May's NPI number?

Lara May's National Provider Identifier (NPI) is 1154498210, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.

What is Lara May's specialty?

Lara May is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).

Where is Lara May located?

Lara May's practice location on file with NPPES is 2901 Richmond Rd, Texarkana, TX 75503.

What is Lara May's phone number?

The practice phone number listed in the NPPES registry for Lara May is (903) 831-5706.

Does Lara May accept Medicare?

Lara May is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.

Is Lara May's NPI active?

Yes — Lara May's NPI (1154498210) is active in the NPPES registry as of the last update on 2017-11-22.

IndividualActiveAccepts Medicare

Lara May, O.D.

NPI 1154498210 · Optometrist · Texarkana, TX

Lara May, O.D. is a Optometrist provider in Texarkana, TX (NPI 1154498210).

Provider details

NPI number: 1154498210
Entity type: Individual
Primary specialty: OptometristEye and Vision Services Providers
Credential: O.D.
Sex: Female
Sole proprietor: No
License: OP0000002198 (TN)

Practice location

2901 Richmond Rd

Texarkana, TX 75503

Phone: (903) 831-5706

Fax: (903) 865-5420

Street-level locationGet directions

More TX providers

Mailing address

2901 Richmond Rd

Texarkana, TX 75503

Specialties & taxonomies

OptometristPrimary152W00000XLicense 5873T (TX)
Eye and Vision Services Providers
Optometrist152W00000XLicense OP0000002198 (TN)
Eye and Vision Services Providers

Enrolled with Medicare as Practitioner - Optometry · source: CMS PECOS Public Provider Enrollment (2026.04.01)

Profile Score

Established profile(69/100 index)

A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.

Registry tenure25% of score
19 yrs in NPPES registry
Profile completeness25% of score
100% of core fields populated
Practice footprint15% of score
1 documented practice location
Medicare service volume (vs. specialty peers)25% of score
23 Medicare services, 2024 (ranked within specialty)
Open Payments transparency10% of score
Has Open Payments disclosures (2024)

Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Complete Exam of Visual System92014	23	$119

Typical Medicare-allowed amounts for these services range $119–$119 (2024). The Medicare-allowed amount is what Medicare recognizes for a service under fee-for-service — a reference figure for 2024, not a price quote and not what you would be billed. Medicare Part B covers roughly an eighth of all NPIs (65+ skew); services with fewer than 11 beneficiaries are suppressed by CMS. Source: CMS Medicare Physician & Other Practitioners, by Provider & Service.

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Prednisolone Acetate	43	30
Cromolyn Sodium	41	30
Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth	14	11
Azelastine Hcl	13	—

Medicare Part D only. These counts cover prescriptions paid through Medicare Part D in 2024 — they do not include cash-pay, commercial-insurance, Medicaid, or Part B–administered drugs, and badly undercount high cash-pay categories (e.g. GLP-1 weight-loss, testosterone, and ED medications). Any drug with 10 or fewer claims is omitted by CMS, and beneficiary counts under 11 are suppressed — so a missing drug means no Part D record, never zero. This is a factual claims summary, not an endorsement, not medical advice, and not a consumer report. Source: CMS Medicare Part D Prescribers — by Provider and Drug.

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$207 across 7 records (Open Payments 2024)

Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.

Enumerated: 2006-11-30
Last updated: 2017-11-22

Frequently asked questions

What is Lara May's NPI number?: Lara May's National Provider Identifier (NPI) is 1154498210, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
What is Lara May's specialty?: Lara May is listed in the NPPES registry with a primary specialty of Optometrist (Eye and Vision Services Providers).
Where is Lara May located?: Lara May's practice location on file with NPPES is 2901 Richmond Rd, Texarkana, TX 75503.
What is Lara May's phone number?: The practice phone number listed in the NPPES registry for Lara May is (903) 831-5706.
Does Lara May accept Medicare?: Lara May is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
Is Lara May's NPI active?: Yes — Lara May's NPI (1154498210) is active in the NPPES registry as of the last update on 2017-11-22.

Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.

What this provider does (Medicare)

Based on Medicare fee-for-service claims, 2024; not all care is captured.

Service (HCPCS)	Medicare services	Typical Medicare-allowed (2024)
Established Patient Complete Exam of Visual System92014	23	$119

What this provider prescribes (Medicare Part D)

Top drugs by Medicare Part D claim volume, 2024 · 4 distinct drugs on file.

Drug	Part D claims (2024)	Beneficiaries
Prednisolone Acetate	43	30
Cromolyn Sodium	41	30
Neomycin/Polymyxin B/Dexamethabrand: Neomycin-Polymyxin-Dexameth	14	11
Azelastine Hcl	13	—

Transparency — industry payments

Based on CMS Open Payments, 2024; not all care is captured.

$207 across 7 records (Open Payments 2024)

Provider details

Practice location

Mailing address

Specialties & taxonomies

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments

Registry dates

Frequently asked questions

Specialties & taxonomies

Frequently asked questions

Profile Score

What this provider does (Medicare)

What this provider prescribes (Medicare Part D)

Transparency — industry payments